BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2014
View Archived Issues
Anti-LFA-1A antibody with utility for targeting alloreactive T cells in kidney allografts
Read More
Astellas Pharma profiles pipeline developments of first quarter of fiscal 2014
Read More
Daya Drug Discoveries profiles novel non-opioid, non-cannabinoid analgesic
Read More
ANI Pharmaceuticals acquires vancomycin assets from Shire
Read More
Bristol-Myers Squibb forms joint venture to advance development of U.S. academic discoveries
Read More
Ignyta licenses two first-in-class kinase inhibitors from Nerviano
Read More
Evolva acquires Prosarix
Read More
Cellular Biomedicine Group to acquire Agreen Biotech
Read More
Regen BioPharma advances development of dCellVax
Read More
Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy
Read More
T-923 enhances the efficacy of CoB-based strategies and promotes transplant tolerance
Read More
Novel MAbs for cancer disclosed by Metheresis Translational Research
Read More
Merck KGaA prepares new cathepsin D inhibitors
Read More
New heterocyclic compounds patented by group in China
Read More
Lupin divulges novel nAChR alpha7 modulators
Read More
Yuhan reports novel glucokinase activators
Read More
NanoViricides to restart anti-Ebola virus drug program
Read More
AB-103 granted orphan product status in the E.U. for soft tissue infections
Read More
Neuraceq launched in Germany
Read More
Phase III ASPIRE trial of Kyprolis meets primary endpoint
Read More
Aegis Therapeutics seeks partnering for exenatide nasal spray
Read More
Octapharma's Nuwiq receives E.U. approval for hemophilia A
Read More
Moerae Matrix begins phase I trial of MMI-0100 for idiopathic pulmonary fibrosis
Read More
Novimmune completes phase I trial of NI-0101
Read More
Rogne Bioscience in-licenses anti-inflammatory peptide for development as psoriasis drug
Read More
Japanese approval sought for monotherapy use of E Keppra Intravenous Drip Infusion
Read More